Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma

por Irvine, Mal, Stewart, Ashleigh, Pedersen, Bernadette, Boyd, Suzanah, Kefford, Richard, Rizos, Helen
Publicado 2018

Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling

por Park, John J., Stewart, Ashleigh, Irvine, Mal, Pedersen, Bernadette, Ming, Zizhen, Carlino, Matteo S., Diefenbach, Russell J., Rizos, Helen
Publicado 2022

Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers

por Shklovskaya, Elena, Pedersen, Bernadette, Stewart, Ashleigh, Simpson, Jack O. G., Ming, Zizhen, Irvine, Mal, Scolyer, Richard A., Long, Georgina V., Rizos, Helen
Publicado 2022

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma

por Lim, Su Yin, Shklovskaya, Elena, Lee, Jenny H., Pedersen, Bernadette, Stewart, Ashleigh, Ming, Zizhen, Irvine, Mal, Shivalingam, Brindha, Saw, Robyn P. M., Menzies, Alexander M., Carlino, Matteo S., Scolyer, Richard A., Long, Georgina V., Rizos, Helen
Publicado 2023